Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets (Unaudited)

v3.22.2
Condensed Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 79,115 $ 30,414
Marketable securities 112,513 130,343
Investment in equity securities 34,008 37,181
Accounts receivable 97,671 12,454
Prepaid expenses and other current assets 8,204 8,123
Total current assets 331,511 218,515
Property and equipment, net 23,600 22,550
Operating lease right-of-use assets 27,716 29,041
Marketable securities, non-current 0 68,775
Other non-current assets 1,921 1,655
Restricted cash 872 872
Total assets 385,620 341,408
Current liabilities:    
Accounts payable 12,567 11,327
Accrued compensation 7,748 11,417
Deferred revenue—current 6,490 5,496
Operating lease liability - current 1,120 1,037
Debt—current 12,500 9,375
Other current liabilities 4,147 3,084
Total current liabilities 44,572 41,736
Deferred revenue - non-current 90,000  
Operating lease liability - non-current 32,069 31,224
Debt—non-current 9,779 15,738
Other noncurrent liabilities 142 146
Total liabilities 176,562 88,844
Commitments and contingencies (Note 7)
Stockholders’ equity:    
Preferred stock, $0.001 par value - 10,000,000 shares authorized as of June 30, 2022 and December 31, 2021; 0 shares issued and outstanding as of June 30, 2022 and December 31, 2021
Common stock, $0.001 par value - 300,000,000 shares authorized as of June 30, 2022 and December 31, 2021; 46,926,859 and 46,327,131 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively 49 46
Additional paid-in-capital 608,898 586,243
Accumulated other comprehensive (loss) income (1,356) (314)
Accumulated deficit (398,533) (333,411)
Total stockholders’ equity 209,058 252,564
Total Liabilities and Stockholders’ Equity $ 385,620 $ 341,408